Neurocrine Biosciences (NBIX) Short-term Investments (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Short-term Investments of $57.4 million for Q2 2026, down 91.9% from $711.6 million a year earlier and down 94.5% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Short-term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences posted Short-term Investments of $767.4 million, down 9.0% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Short-term Investments came in at $843.1 million in FY2024 (+8.0%), $780.5 million in FY2023 (+7.4%), $726.4 million in FY2022 (+96.1%) and $370.5 million in FY2021 (-39.6%).
- The Q2 2026 figure ranks as the lowest quarterly Short-term Investments in data going back to Q4 2010.
- Year over year, Short-term Investments gained in three of the last eight quarters, with an average decline of 10.5%.
- The high point for year-over-year Short-term Investments in five years was Q1 2023 (growth of 100.4%); the low point was Q2 2026 (a decline of 91.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.05 billion (Q1 2026), $767.4 million (Q4 2025) and $774.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.30 Bn | 9.99 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.40 Mn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 767.40 Mn |
| Sep 30, 2025 | 774.60 Mn |
| Jun 30, 2025 | 711.60 Mn |
| Mar 31, 2025 | 749.40 Mn |
| Dec 31, 2024 | 843.10 Mn |
| Sep 30, 2024 | 878.90 Mn |
| Jun 30, 2024 | 899.20 Mn |
| Mar 31, 2024 | 814.30 Mn |
| Dec 31, 2023 | 780.50 Mn |
| Sep 30, 2023 | 801.40 Mn |
| Jun 30, 2023 | 816.50 Mn |
| Mar 31, 2023 | 790.80 Mn |
| Dec 31, 2022 | 726.40 Mn |
| Sep 30, 2022 | 587.20 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 394.70 Mn |
| Dec 31, 2021 | 370.50 Mn |
| Sep 30, 2021 | 454.80 Mn |
API Access
Neurocrine Biosciences Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();